CC
Checkpoint Capital Portfolio holdings
AUM
$215M
This Quarter Return
+4.4%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$196M
AUM Growth
+$196M
(-2.5%)
Cap. Flow
+$2.23M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
91.55%
Holding
18
New
2
Increased
9
Reduced
4
Closed
2
Top Buys
| 1 |
Disc Medicine
IRON
|
$10.1M |
| 2 |
Revolution Medicines
RVMD
|
$9.19M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$6.25M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$3.62M |
| 5 |
Trevi Therapeutics
TRVI
|
$3.44M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$21M |
| 2 |
Protagonist Therapeutics
PTGX
|
$10.8M |
| 3 |
ATYR
aTyr Pharma
ATYR
|
$4.72M |
| 4 |
Axsome Therapeutics
AXSM
|
$2.95M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$43.6B
| $56.9M | 28.95% |
92,500
| – | – |
|
|
2
Rhythm Pharmaceuticals
RYTM
$6.85B
| $40.8M | 20.74% |
727,982
+64,601
| +10% | +$3.62M |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $18.5M | 9.4% |
2,274,157
+769,850
| +51% | +$6.25M |
|
|
4
Axsome Therapeutics
AXSM
$6.05B
| $14.8M | 7.53% |
174,769
-34,863
| -17% | -$2.95M |
|
|
5
Disc Medicine
IRON
$2.07B
| $11.7M | 5.97% |
185,000
+159,457
| +624% | +$10.1M |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.43B
| $10.6M | 5.37% |
1,004,790
-95,210
| -9% | -$1M |
|
|
7
Revolution Medicines
RVMD
$7.1B
| $9.19M | 4.68% |
+210,000
| New | +$9.19M |
|
8
Pliant Therapeutics
PLRX
$101M
| $7.05M | 3.59% |
535,494
+155,494
| +41% | +$2.05M |
|
9
TScan Therapeutics
TCRX
$102M
| $5.34M | 2.72% |
1,755,987
+930,646
| +113% | +$2.83M |
|
10
Cidara Therapeutics
CDTX
$1.66B
| $5.11M | 2.6% |
196,949
+14,523
| +8% | +$377K |
|
|
11
Trevi Therapeutics
TRVI
$883M
| $4.47M | 2.27% |
1,084,135
+834,135
| +334% | +$3.44M |
|
12
Stoke Therapeutics
STOK
$1.08B
| $3.37M | 1.71% |
305,387
+147,873
| +94% | +$1.63M |
|
13
Soleno Therapeutics
SLNO
$3.6B
| $3.15M | 1.6% |
70,027
+12,044
| +21% | +$541K |
|
14
Kymera Therapeutics
KYMR
$2.95B
| $3.12M | 1.59% |
+77,535
| New | +$3.12M |
|
|
ATYR
15
aTyr Pharma
ATYR
$527M
| $1.57M | 0.8% |
432,561
-1,303,916
| -75% | -$4.72M |
|
|
16
Cytokinetics
CYTK
$4.23B
| $941K | 0.48% |
20,000
-446,813
| -96% | -$21M |
|
|
ALLK
17
DELISTED
Allakos
ALLK
| – | – |
-649,957
| Closed | -$425K |
|
|
18
Protagonist Therapeutics
PTGX
$3.67B
| – | – |
-240,000
| Closed | -$10.8M |
|